MARKET

VIVE

VIVE

Viveve Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.5100
-0.0199
-3.76%
After Hours: 0.5100 0 0.00% 16:37 10/28 EDT
OPEN
0.5249
PREV CLOSE
0.5299
HIGH
0.5269
LOW
0.5000
VOLUME
336.50K
TURNOVER
--
52 WEEK HIGH
5.38
52 WEEK LOW
0.4800
MARKET CAP
8.02M
P/E (TTM)
-0.0265
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Viveve Launches New Clinical Advisory Board In Urinary Incontinence
Preeminent urology and urogynecology experts to help guide and advance the company's pivotal U.S. PURSUIT trial in Stress Urinary Incontinence ENGLEWOOD, CO / ACCESSWIRE / October 27, 2020 / Viveve Medical, Inc.
Benzinga · 1d ago
The Daily Biotech Pulse: Novavax Advances Vaccine, Marinus Gets Nod For Late-Stage Study, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 24)
Benzinga · 09/25 11:37
Viveve Medical issued method patent for stress urinary incontinence
Viveve Medical ([[VIVE]] +4.4%) announces that the United States Patent and Trademark Office (‘USPTO’) has issued U.S. Patent No. 10,779,874 covering Viveve's unique method of treatment to address stress urinary
Seekingalpha · 09/22 15:27
Viveve Announces Issuance Of Novel US Method Patent For Stress Urinary Incontinence
New patent strengthens and expands Viveve's intellectual property portfolio for the treatment of stress urinary incontinence ENGLEWOOD, CO / ACCESSWIRE / September 22, 2020 / Viveve Medical, Inc.
Benzinga · 09/22 12:28
The Daily Biotech Pulse: Legal Relief For Evolus, Fulgent to Join S&P SmallCap 600, AIM ImmunoTech's Positive Cancer Drug Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 21)
Benzinga · 09/22 11:59
Viveve to Present at H.C. Wainwright 22nd Annual Global Investment Conference
ENGLEWOOD, CO / ACCESSWIRE / September 3, 2020 / Viveve Medical, Inc.
ACCESSWIRE · 09/03 12:28
Viveve Announces Exercise of Warrants for $3.6 Million
* Proceeds to support upcoming pivotal PURSUIT Trial in U.
ACCESSWIRE · 09/01 13:28
Overview Of Value Stocks In The Healthcare Sector
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.Benzinga Insights
Benzinga · 08/31 13:41
More
Forecast
EPSBVPSCFPS
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VIVE. Analyze the recent business situations of Viveve Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average VIVE stock price target is 1.850 with a high estimate of 1.850 and a low estimate of 1.850.
EPS
Institutional Holdings
Institutions: 44
Institutional Holdings: 20.34M
% Owned: 129.29%
Shares Outstanding: 15.73M
TypeInstitutionsShares
Increased
2
280.11K
New
7
-17.55K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-3.82%
Healthcare Equipment & Supplies
-3.30%
Key Executives
Chairman/Independent Director
Steven Basta
Chief Executive Officer/Director
Scott Durbin
Chief Financial Officer/Vice President - Finance
Jim Robbins
Vice President
Sean Shapiro
Director
Debora Jorn
Independent Director
Arlene Morris
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About VIVE
Viveve Medical, Inc. designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company's, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console. The generator authenticates the treatment tip and programs the system for the desired treatment without further physician intervention. The treatment is performed in a physician's office, in less than 30 minutes, and does not require the use of anesthesia. Geneveve is indicated for use in general surgical procedures for electrocoagulation and hemostasis in the United States.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Viveve Medical Inc stock information, including NASDAQ:VIVE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIVE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VIVE stock methods without spending real money on the virtual paper trading platform.